Literature DB >> 27139233

Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF.

George R Breese1, Darin J Knapp2.   

Abstract

This review updates the conceptual basis for the association of alcohol abuse with an insidious adaptation that facilitates negative affect during withdrawal from chronic intermittent alcohol (CIA) exposure - a change that later supports sensitization of stress-induced anxiety following alcohol abstinence. The finding that a CRF1-receptor antagonist (CRF1RA) minimized CIA withdrawal-induced negative affect supported an association of alcohol withdrawal with a stress mechanism. The finding that repeated stresses or multiple CRF injections into selected brain sites prior to a single 5-day chronic alcohol (CA) exposure induced anxiety during withdrawal provided critical support for a linkage of CIA withdrawal with stress. The determination that CRF1RA injection into positive CRF-sensitive brain sites prevented CIA withdrawal-induced anxiety provided support that neural path integration maintains the persistent CIA adaptation. Based upon reports that stress increases neuroimmune function, an effort was undertaken to test whether cytokines would support the adaptation induced by stress/CA exposure. Twenty-four hours after withdrawal from CIA, cytokine mRNAs were found to be increased in cortex as well as other sites in brain. Further, repeated cytokine injections into previously identified brain sites substituted for stress and CRF induction of anxiety during CA withdrawal. Discovery that a CRF1RA prevented the brain cytokine mRNA increase induced by CA withdrawal provided critical evidence for CRF involvement in this neuroimmune induction after CA withdrawal. However, the CRF1RA did not block the stress increase in cytokine mRNA increases in controls. The latter data supported the hypothesis that distinct mechanisms linked to stress and CA withdrawal can support common neuroimmune functions within a brain site. As evidence evolves concerning neural involvement in brain neuroimmune function, a better understanding of the progressive adaptation associated with CIA exposure will advance new knowledge that could possibly lead to strategies to combat alcohol abuse.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptation; Anxiety; CRF; Chronic alcohol withdrawal; Neuroimmune; Stress

Mesh:

Substances:

Year:  2016        PMID: 27139233      PMCID: PMC4855305          DOI: 10.1016/j.alcohol.2016.01.005

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  210 in total

1.  Rat strain differences in restraint stress-induced brain cytokines.

Authors:  V M Porterfield; Z R Zimomra; E A Caldwell; R M Camp; K M Gabella; J D Johnson
Journal:  Neuroscience       Date:  2011-05-18       Impact factor: 3.590

2.  HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

Authors:  Jung-Bin Kim; Joon Sig Choi; Young-Mi Yu; Kihoon Nam; Chun-Shu Piao; Seung-Woo Kim; Min-Hyung Lee; Pyung-Lim Han; Jong-Sang Park; Ja-Kyeong Lee
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

3.  Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices.

Authors:  Yan Zhou; Hongmei Tang; Jianuo Liu; Jun Dong; Huangui Xiong
Journal:  J Neurochem       Date:  2010-12-13       Impact factor: 5.372

Review 4.  The neuropoietic cytokine family in development, plasticity, disease and injury.

Authors:  Sylvian Bauer; Bradley J Kerr; Paul H Patterson
Journal:  Nat Rev Neurosci       Date:  2007-03       Impact factor: 34.870

5.  Interleukin-1β causes anxiety by interacting with the endocannabinoid system.

Authors:  Silvia Rossi; Lucia Sacchetti; Francesco Napolitano; Valentina De Chiara; Caterina Motta; Valeria Studer; Alessandra Musella; Francesca Barbieri; Monica Bari; Giorgio Bernardi; Mauro Maccarrone; Alessandro Usiello; Diego Centonze
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

6.  Single neuron activity changes to interleukin-1beta in the orbitofrontal cortex of the rat.

Authors:  Balázs Lukáts; Róbert Egyed; Zoltán Karádi
Journal:  Brain Res       Date:  2005-03-21       Impact factor: 3.252

7.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

8.  The relationship between alcohol consumption and cortisol secretion in an aging cohort.

Authors:  Ellena Badrick; Martin Bobak; Annie Britton; Clemens Kirschbaum; Michael Marmot; Meena Kumari
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

9.  The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress.

Authors:  Darin J Knapp; David H Overstreet; Robert A Angel; Montserrat Navarro; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2007-09-26       Impact factor: 3.455

10.  TLR4 mediates the impairment of ubiquitin-proteasome and autophagy-lysosome pathways induced by ethanol treatment in brain.

Authors:  A Pla; M Pascual; J Renau-Piqueras; C Guerri
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

View more
  10 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

2.  Stress and Alcohol Priming of Brain Toll-Like Receptor Signaling in Alcohol Use Disorder.

Authors:  Fulton T Crews; Ryan P Vetreno
Journal:  Alcohol Alcohol       Date:  2018-11-01       Impact factor: 2.826

3.  Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity.

Authors:  Irina Balan; Kaitlin T Warnock; Adam Puche; Marjorie C Gondre-Lewis; Laure Aurelian
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

Review 4.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

Review 5.  FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.

Authors:  Michael T Bowen; Olivier George; Dawn E Muskiewicz; F Scott Hall
Journal:  Neurosci Biobehav Rev       Date:  2021-11-25       Impact factor: 8.989

Review 6.  A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

Authors:  A Leslie Morrow; Giorgia Boero; Patrizia Porcu
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

Review 7.  Role of corticotropin-releasing factor in alcohol and nicotine addiction.

Authors:  Sierra Simpson; Kokila Shankar; Adam Kimbrough; Olivier George
Journal:  Brain Res       Date:  2020-04-21       Impact factor: 3.252

8.  Stress and Withdrawal from Chronic Ethanol Induce Selective Changes in Neuroimmune mRNAs in Differing Brain Sites.

Authors:  Darin J Knapp; Kathryn M Harper; Buddy A Whitman; Zachary Zimomra; George R Breese
Journal:  Brain Sci       Date:  2016-07-27

9.  Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease.

Authors:  Giorgia Boero; Patrizia Porcu; A Leslie Morrow
Journal:  Neurobiol Stress       Date:  2019-11-27

10.  Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement.

Authors:  Tessa L Steel; Majid Afshar; Scott Edwards; Sarah E Jolley; Christine Timko; Brendan J Clark; Ivor S Douglas; Amy L Dzierba; Hayley B Gershengorn; Nicholas W Gilpin; Dwayne W Godwin; Catherine L Hough; José R Maldonado; Anuj B Mehta; Lewis S Nelson; Mayur B Patel; Darius A Rastegar; Joanna L Stollings; Boris Tabakoff; Judith A Tate; Adrian Wong; Ellen L Burnham
Journal:  Am J Respir Crit Care Med       Date:  2021-10-01       Impact factor: 21.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.